Attached files
| file | filename |
|---|---|
| 8-K - Emmaus Life Sciences, Inc. | v175335_8k.htm |
 Investor
Relations:
Marty
Tullio, Managing Partner
McCloud
Communications, LLC
949.553.9748
marty@mccloudcommunications.com
|
 |
CNS
Response Names Paul Buck Its Chief Financial Officer
Aliso
Viejo,
CA – February 18, 2010 – CNS
Response, Inc. (OTCBB:CNSO) today named Paul Buck as its chief
financial officer. Mr. Buck has been working with CNS Response as a financial
consultant since December 2008.
Prior to
joining CNS Response, Mr. Buck worked as an independent consultant and has a
broad range of experience with a variety of public companies. His projects
included forensic accounting, mergers and acquisitions, interim management, and
systems implementations. Buck started his career with Touche Ross & Company
in Cape Town, South Africa, where he qualified as a Chartered Accountant. In
1985 he joined the Los Angeles office of Touche Ross & Company, where he was
an audit manager. In 1991 he joined the American Red Cross Biomedical Services
as CFO of the Southern California Region and after five years, returned to
Deloitte & Touche as a manager in the Solutions Consulting
Group. He was recruited back to the American Red Cross Biomedical
Services in 1998 and served as the CFO and Director of Operations for the
Southern California Region until 2003.
Mr. Buck,
a Swiss National, was raised in Southern Africa and holds a Bachelor of Science
degree in Chemistry and a Bachelor of Commerce degree, both from the University
of Cape Town, South Africa.
“Paul is
a versatile, experienced finance executive who has done an outstanding job for
us over the past year,” said CNS Response CEO George Carpenter. “His proven
leadership skills, strong track record and hands-on approach will further
strengthen our management team. We look forward to benefiting from his expertise
as we drive commercialization of our services within the healthcare
industry.”
Reporting
directly to CEO George Carpenter, Buck will be responsible for all financial
aspects of the company including accounting oversight, financial reporting and
analysis, and budgeting. He will be the point of contact for all outside
accounting and advisory firms.
About
CNS Response
Today,
most physicians are able to base treatment on objective test data, such as EKGs,
MRIs, blood tests, etc. Broadly speaking, such advances have not yet come
to those physicians practicing psychiatry.
CNS
Response has developed a patented data-analysis capability that, with the help
of a simple, non-invasive EEG, will analyze a patient’s brain waves and compare
the results to an extensive patient outcomes database. The process produces a
rEEG® report
providing a psychiatrist with guidance to personalize medication regimens for a
patient, based on the patient’s own brain physiology. To read more about
the benefits this patented technology provides physicians, patients and
insurers, please visit www.cnsresponse.com.
-
more -
CNS
Response Names Paul Buck Its Chief Financial Officer
Page
2
Safe
Harbor Statement under the Private Securities Litigation Reform Act of
1995
Except
for the historical information contained herein, the matters discussed are
forward-looking statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995, as amended. These statements
involve risks and uncertainties as set forth in the Company's filings with the
Securities and Exchange Commission. These risks and uncertainties could cause
actual results to differ materially from any forward-looking statements made
herein.
# #
#